You are here

Douglas Page
 - Amyvid
Molecular Imaging

The practice management considerations, as well as uncertainty about the meaning of a beta-amyloid, scan are impacting early adopters.

 - Mark S. Schechter, MD
Health Imaging

Florbetapir could change how dementia is diagnosed, but it may be hampered by practice management and clinical challenges.

 - Senior man
Molecular Imaging

Advancements in molecular neuroimaging are providing new ways to assess neuroinflammation in the brain.

 - Lung Cancer
Molecular Imaging

The final diagnostic form the evolving hybrid PET/MR tree will take is uncertain, but it has already begun to blossom. Thus, the low-hanging clinical fruit has lured a number of medical centers to early adoption. Experts weigh in on the potential that PET/MR may hold for various neurologic, oncologic and cardiovascular conditions.

 - PET/MR Whole Body Scan
Health Imaging
The final diagnostic form the evolving hybrid PET/MR tree will take is uncertain, but it has already begun to blossom. In fact, low-hanging clinical fruit has lured a number of major medical centers to early adoption.